PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial Meeting Abstract
| Authors: | Lacouture, M. E.; McArthur, G. A.; Chapman, P. B.; Ribas, A.; Flaherty, K. T.; Lee, R. J.; Nolop, K. B.; Kim, K. B.; Duvic, M.; Sosman, J. A.; Dermatology Working Group |
| Abstract Title: | PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 634s |
| Language: | English |
| ACCESSION: | WOS:000208852005262 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2010.28.15_suppl.8592 |
| Notes: | Meeting Abstract: 8592 -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
